Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Kalaris Therapeutics, Inc. | 453 529 | déclaré | 04 oct. 2021 | tx 14+345 700−121 586 |
| Forma Therapeutics Holdings, Inc., | 0 | déclaré | 14 oct. 2022 | tx 4+197 000−197 000 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 14 oct. 2022 | TENDER | Forma Therapeutics Holdings, Inc., | 79 000 | — | |
| 14 oct. 2022 | OTHER | Forma Therapeutics Holdings, Inc., | 118 000 | — | deriv |
| 11 juil. 2022 | GRANT_AWARD | Forma Therapeutics Holdings, Inc., | 79 000 | 0.00 USD | |
| 11 juil. 2022 | GRANT_AWARD | Forma Therapeutics Holdings, Inc., | 118 000 | 0.00 USD | deriv |
| 04 oct. 2021 | SALE | Kalaris Therapeutics, Inc. | 10 678 | 23.29 USD | |
| 04 oct. 2021 | SALE | Kalaris Therapeutics, Inc. | 333 | 26.02 USD | |
| 04 oct. 2021 | SALE | Kalaris Therapeutics, Inc. | 2 967 | 25.41 USD | |
| 04 oct. 2021 | SALE | Kalaris Therapeutics, Inc. | 4 711 | 24.23 USD | |
| 28 sept. 2021 | SALE | Kalaris Therapeutics, Inc. | 3 750 | 24.12 USD | |
| 15 sept. 2021 | SALE | Kalaris Therapeutics, Inc. | 800 | 24.03 USD | |
| 02 juil. 2021 | SALE | Kalaris Therapeutics, Inc. | 18 586 | 19.99 USD | |
| 05 avr. 2021 | SALE | Kalaris Therapeutics, Inc. | 18 212 | 23.89 USD | |
| 17 sept. 2021 | SALE | Kalaris Therapeutics, Inc. | 2 950 | 24.01 USD | |
| 22 mars 2021 | SALE | Kalaris Therapeutics, Inc. | 3 750 | 25.97 USD | |
| 02 févr. 2021 | SALE | Kalaris Therapeutics, Inc. | 54 849 | 41.19 USD | |
| 19 janv. 2021 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 43 750 | 0.00 USD | |
| 19 janv. 2021 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 81 250 | 0.00 USD | deriv |
| 29 juil. 2020 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 220 700 | 0.00 USD | deriv |